New England Journal of Medicine , 384 (11), 9891002.
doi:10.1016/j.ctim.2017.09.010
Customer Amy Spencer pays only $50/month for a concoction that mimics the effect of brand Wegovy/Zepbound, compared to ~$500/month commercial cost ( [7] )
"Obviously, we have the expansive platform, whether it's the oral medications that are already out there or if there is some reason that this patient would qualify for some level of personalization that exists
For example, high mobility group box 1 (HMGB1), as a DAMP, is released in an autophagy-dependent manner by ferroptosis inducers and mediates inflammatory responses through the HMGB1-advanced glycation end-product-specific receptor (AGER) pathway, a pathway that activates the NF-B pathway in innate immunity [94]
Cells 8 , 1110 (2019)